Treatment of intracranial atherosclerotic stenosis.
Atherosclerotic stenosis of the major intracranial arteries is an important cause of ischemic stroke. Antiplatelet agents and aggressive management of atherosclerotic risk factors, including hypertension, should play a central role in the prevention of vascular events in patients with intracranial arterial stenosis. Angioplasty and stenting are also among current therapeutic options. A randomized controlled trial of intracranial stenting plus aggressive medical therapy versus aggressive medical therapy alone is needed to determine the optimal treatment for patients with severe symptomatic intracranial stenosis.
Department of Neurosciences, Division of Neurology, Medical University of South Carolina, Charleston, SC, USA.
Tanya N
TN
Turan
Marc I
MI
Chimowitz
D017130:Angioplasty / Q000379:methods; D001488:Basilar Artery / Q000473:pathology; D001921:Brain / Q000098:blood supply; D002339:Carotid Arteries / Q000473:pathology; D002548:Cerebral Revascularization / Q000379:methods*; D003251:Constriction, Pathologic / Q000473:pathology / Q000628:therapy; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006801:Humans; D002537:Intracranial Arteriosclerosis / Q000150:complications / Q000628:therapy*; D020768:Middle Cerebral Artery / Q000473:pathology; D015607:Stents; D020521:Stroke / Q000517:prevention & control*; D014711:Vertebral Artery / Q000473:pathology
D005343:Fibrinolytic Agents